Historical record - last NADAC effective date: 2/22/2023
Product Information
BUPROPION HCL XL 150 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.1054 per EA under NDC 43598065505. Its NADAC has been published 281 times since Oct 11, 2017.
FDA first approved this application on Apr 12, 2017. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598065505
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
2/22/2023
Active Ingredients
BUPROPION HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207479FDA Approved
4/12/2017
TE Code
AB3
On Market Since
4/12/2017
Pharmacological Classes
Price Statistics
The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 281 times since Oct 11, 2017, and over the history we have for it it has declined 73.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1054 per EA |
|---|---|
| All-time high | $0.4043 (Oct 11, 2017) |
| All-time low | $0.1000 (Jan 18, 2023) |
| Median price | $0.1930 |
| Average price | $0.2171 |
| Largest weekly change | +28.5% (Dec 23, 2020) |
| Weeks tracked | 281 |
| Tracking since | Oct 11, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
-32.5%
All
-73.9%
Last surveyed Feb 22, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.1054 per EA (NDC 43598065505), effective Feb 22, 2023.
How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 73.9%. It has been tracked across 281 weekly CMS publications since Oct 11, 2017.
What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?
Since Oct 11, 2017, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.1000 (Jan 18, 2023) to a high of $0.4043 (Oct 11, 2017), with a median of $0.1930 per EA.
Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?
Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0779 per EA — about 26% below BUPROPION HCL XL 150 MG TABLET.
Who manufactures BUPROPION HCL XL 150 MG TABLET?
BUPROPION HCL XL 150 MG TABLET (NDC 43598065505) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.